•MDConsult AI debuts pre-consultation platform for surgical practices•Tarsus to purchase Alkeus Pharmaceuticals•NSAID use may lower AMD risk•4DMT reports new phase 2b gene therapy data for wet AMD•Glaukos completes enrollment in PRESERFLO MicroShunt pivotal study•MDConsult AI debuts pre-consultation platform for surgical practices•Tarsus to purchase Alkeus Pharmaceuticals•NSAID use may lower AMD risk•4DMT reports new phase 2b gene therapy data for wet AMD•Glaukos completes enrollment in PRESERFLO MicroShunt pivotal study
HEADLINES
FEATURED
Pending acquisition of Viatris's FDA-approved, varenicline nasal spray is worth up to $100 million and is expected to close by the end of 2026.
Earn FREE CE 24/7 with Courses by Eyes On Eyecare
Explore premium-quality, bite-sized courses featuring leading experts like Cecelia Koetting, OD, FAAO, and Cory Lappin, OD, MS, FAAO, and continuing education covering topics from ocular rosacea treatments to retinal disease.
![[object Object]](/_next/image/?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F51cpf7jm%2Fproduction%2F0fbac34bad6d09f82e441f0027ebe861bc590ab8-1200x628.png%3Fw%3D2400%26q%3D100%26fit%3Dfill%26auto%3Dformat&w=3840&q=75)
